200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 173352-21-1

173352-21-1

173352-21-1 | 1H-Benzimidazole, 6-ethoxy-2-[[2-(4-morpholinyl)ethyl]thio]-

CAS No: 173352-21-1 Catalog No: AG001YTS MDL No:

Product Description

Catalog Number:
AG001YTS
Chemical Name:
1H-Benzimidazole, 6-ethoxy-2-[[2-(4-morpholinyl)ethyl]thio]-
CAS Number:
173352-21-1
Molecular Formula:
C15H21N3O2S
Molecular Weight:
307.4111
IUPAC Name:
4-[2-[(6-ethoxy-1H-benzimidazol-2-yl)sulfanyl]ethyl]morpholine
InChI:
InChI=1S/C15H21N3O2S/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17)
InChI Key:
WWNUCVSRRUDYPP-UHFFFAOYSA-N
SMILES:
CCOc1ccc2c(c1)[nH]c(n2)SCCN1CCOCC1
UNII:
0F8K1X115C

Properties

Complexity:
315  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
307.135g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
307.412g/mol
Monoisotopic Mass:
307.135g/mol
Rotatable Bond Count:
6  
Topological Polar Surface Area:
75.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  

Literature

Title Journal
Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice. Bulletin of experimental biology and medicine 20120901
[Afobazole effect on the electrical activity of neurons]. Eksperimental'naia i klinicheskaia farmakologiia 20120101
Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors. The Journal of pharmacology and experimental therapeutics 20111001
Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors. The Journal of pharmacology and experimental therapeutics 20111001
Effects of afobazole on the content of neurotransmitter amino acids in the striatum in global transient ischemia. Bulletin of experimental biology and medicine 20110901
Effects of afobazole on cognitive behavior of the offspring of rats exposed to tobacco smoke during gestation period. Bulletin of experimental biology and medicine 20110501
Anxiety and predisposition to audiogenic epilepsy in rats of different genotypes. Bulletin of experimental biology and medicine 20110501
Study of anti-ischemic effect of afobazole in experimental myocardial infarction. Bulletin of experimental biology and medicine 20110101
[Influence of anxiolytic afobazole on amygdalar neuronal activity and behavior of rabbits in emotionally negative situations]. Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20110101
[Pharmacokinetics of afobazole metabolite (M-11) in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Association of genotoxic and teratogenic effects induced by cyclophosphamide and their modification with afobazole]. Gigiena i sanitariia 20110101
[Analysis of the binding capacity of the benzodiazepine site of gabaa receptor in mice C57BL/6 and BALB/C pretreated with anxiolytics]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Effect of afobazole on the psychophysiological state of healthy volunteers]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Possible role of serotonin 5-HT2 receptors in mechanism of afobazole anxiolytic action: neurochemical study of inter-line differences in mice]. Eksperimental'naia i klinicheskaia farmakologiia 20110101
[Comparative study of the interoceptive effects of afobazole and diazepam]. Eksperimental'naia i klinicheskaia farmakologiia 20101001
[Anxiolytic afobazole action self-evaluated by patients with anxiety-asthenic disorders]. Eksperimental'naia i klinicheskaia farmakologiia 20100901
Effect of afobazole on genotoxic effects of tobacco smoke in the placenta and embryonic tissues of rats. Bulletin of experimental biology and medicine 20100901
On the mechanism of antifibrillatory effect of afobazole. Bulletin of experimental biology and medicine 20100901
Comparative analysis of tissue availability for afobazole and compound M-11. Bulletin of experimental biology and medicine 20100901
[Model study of afobazole distribution in pregnant and lactating female rats and infant rat pups]. Eksperimental'naia i klinicheskaia farmakologiia 20100801
Effects of selective anxiolytic afobazole on active caspase-3. Bulletin of experimental biology and medicine 20100801
Neuroprotective properties of afobazole in repeated hemorrhagic stroke modeling in aged rats. Bulletin of experimental biology and medicine 20100801
[Cerebrovascular effects of afobazole under conditions of combined disorders of cerebral and coronary circulation]. Eksperimental'naia i klinicheskaia farmakologiia 20100501
[Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives]. Eksperimental'naia i klinicheskaia farmakologiia 20100501
[Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015]. Eksperimental'naia i klinicheskaia farmakologiia 20100301
[Effects of afobasol in the reperfusion arrhythmia model]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20100101
[Afobasol antifibrillation activity in animals with the intact and denervated myocardium]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20100101
[Afobasol efficacy in a model of vagotonic atrial fibrillation]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20100101
[Effectiveness of combined application of ursosan and anxiolytic 2-mercaptobenzimidazole in early stage of cholelithiasis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101
Effect of afobazole on DNA damage in patients with systemic lupus erythematosus. Bulletin of experimental biology and medicine 20091001
Effect of afobazole on mitochondrial monoamine oxidase A activity in vitro. Bulletin of experimental biology and medicine 20090701
Interaction of afobazole with sigma1-receptors. Bulletin of experimental biology and medicine 20090701
[Neuroreceptor mechanisms of the afobazole effect]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Selective anxiolytic afobazole increases the content of BDNF and NGF in cultured hippocampal HT-22 line neurons]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Afobazole decreases motor side effects induced by haloperidol]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Antidepressant properties of afobazole in Porsolt and Nomura tests]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Afobazole influence on antinociceptive properties of morphine]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Neuroprotective effects of afobazole in a hemorrhagic stroke model]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Effects of afobazole on the stress protein HSP70 level in the brain tissue of rats with global transient ischemia]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Afobazole effect on heart rate variability in rats with different behaviors in the 'open field' test]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Specific effects of selective anxiolytic afobazole on the cardiovascular system]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Antimutagenic and antiteratogenic properties of afobazole]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
[Afobazole effect on cerebral circulation under hemorrhagic stroke model conditions]. Eksperimental'naia i klinicheskaia farmakologiia 20090101
Gateways to clinical trials. December 2008. Methods and findings in experimental and clinical pharmacology 20081201
Effect of afobazole on teratogenic activity of cyclophosphamide in rats. Bulletin of experimental biology and medicine 20080401
Excretion of afobazole and its metabolites with urine and feces in rats. Bulletin of experimental biology and medicine 20080401
Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex. Bulletin of experimental biology and medicine 20080201
[Afobazole metabolism in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20080101
[Efficacy of aphobazole in the treatment of anxiety disorders in patients with chronic cerebro-vascular insufficiency]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
[Administration of afobasol for correction of mental disorders in celiac disease patients]. Terapevticheskii arkhiv 20080101
[Using of aphobazol in the treatment of adaptation disorder in the contract service men, dismissed from the armed forces]. Voenno-meditsinskii zhurnal 20071101
Tissue availability of afobazole and its major metabolites in rats. Bulletin of experimental biology and medicine 20070501
[Pharmacokinetics of afobazole in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20070101
In vivo effects of afobazole (2-mercaptobenzimidazole derivative) on the 7,12-dimethylbenz [alpha]anthracene-induced oncogene and suppressor gene expression. In vivo (Athens, Greece) 20070101
[Psychopharmacotherapy of anxiety disorders in patients with cardio-vascular diseases: the use of aphobazole]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20070101
Studies of long-term noopept and afobazol treatment in rats with learned helplessness neurosis. Bulletin of experimental biology and medicine 20060801
[Effect of afobazole on brain-ischemia-induced anxiety in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
[Effects of afobazole on the BDNF content in brain structures of inbred mice with different phenotypes of emotional stress reaction]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
[Evidence for the neuroprotective properties of afobazole in experimental model of focal brain ischemia]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
[Effect of afobazole on the accumulation of free radical oxidation products and the catalase activity in rats with cerebral ischemia]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
[A comparative study of the effect of afobazole on brain monoamine systems in BALB/C and C57BL/6 mice]. Eksperimental'naia i klinicheskaia farmakologiia 20060101
Neuroprotective effects of afobazol in experimental cerebral hemorrhage. Bulletin of experimental biology and medicine 20051101
Neuroprotective properties of afobazol in vitro. Bulletin of experimental biology and medicine 20050801
[Gabaergic mechanism of cerebrovascular and neuroprotective effects of afobazole and picamilon]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
[Aphobazol--new selective anxyolytic drug]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
[Using aphobazol for treatment of the emotional stress after exposure to ionizing radiation]. Patologicheskaia fiziologiia i eksperimental'naia terapiia 20050101
[Effect of afobazole on transmembrane ion currents in mollusk neurons]. Eksperimental'naia i klinicheskaia farmakologiia 20050101
[Afobazole increases cerebral blood flow in rats with global brain ischemia]. Eksperimental'naia i klinicheskaia farmakologiia 20040101
Effect of noopept and afobazole on the development of neurosis of learned helplessness in rats. Bulletin of experimental biology and medicine 20030801
[Pharmacological correction of emotional stress after exposure to ionizing radiation and treatment with a radioprotector indralin]. Radiatsionnaia biologiia, radioecologiia 20030101
[Comparative electroencephalographic evaluation of anxiolytics afobazol and diazepam in MR and MNRA inbred rats with different anxiety levels]. Eksperimental'naia i klinicheskaia farmakologiia 20030101
[Pharmacological regulation of emotional stress reactions]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20030101
[State of hemopoiesis under exposure to low doses of ionizing radiation and emotional stress during treatment with anxiolytic aphobazole]. Radiatsionnaia biologiia, radioecologiia 20010101
[Clinical study of the selective anxiolytic agent afobazol]. Eksperimental'naia i klinicheskaia farmakologiia 20010101
[Effect of novel anxiolytic agent aphobazole on coherence of the brain biopotentials in MR and MNRA rats]. Eksperimental'naia i klinicheskaia farmakologiia 20010101

Related Products

© 2019 Angene International Limited. All rights Reserved.